-
Something wrong with this record ?
Synthesis of 2-aryl-4-(benzimidazol-2-yl)-1,2-dihydro[1,2,4]triazino-[4,5-a]benzimidazol-1-one derivatives with preferential cytotoxicity against carcinoma cell lines
J Styskala, L Styskalova, J Slouka, M Hajduch
Language English Country France
- MeSH
- Benzimidazoles pharmacology chemical synthesis chemistry toxicity MeSH
- Financing, Organized MeSH
- Humans MeSH
- Cell Line, Tumor MeSH
- Cell Proliferation drug effects MeSH
- Antineoplastic Agents pharmacology chemical synthesis chemistry toxicity MeSH
- Drug Design MeSH
- Sensitivity and Specificity MeSH
- Check Tag
- Humans MeSH
In this paper we describe the preparation of some derivatives of 1,2,4-triazino[4,5-a]benzimidazol-1-ones (5 and 6), containing additional benzimidazole ring. These compounds were prepared using coupling reactions of diazonium salts with 1,1-bis(1-ethoxycarbonyl-benzimidazol-2-yl)methane (2) to obtain unstable hydrazones 4, which readily undergo cyclization. Interestingly, the selected compounds demonstrated preferential cytotoxic activities against human carcinoma and glioma cell lines compared with leukemic cells. They showed significant activity against multidrug-resistant P-glycoprotein expressing cell lines but had less effect on multidrug-resistance protein 1 positive and topoisomerase IIalpha negative leukemias.
- 000
- 02427naa 2200397 a 4500
- 001
- bmc11002988
- 003
- CZ-PrNML
- 005
- 20121203121110.0
- 008
- 110225s2008 fr e eng||
- 009
- AR
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a fr
- 100 1_
- $a Stýskala, Jakub, $d 1972- $7 ola2005284375
- 245 10
- $a Synthesis of 2-aryl-4-(benzimidazol-2-yl)-1,2-dihydro[1,2,4]triazino-[4,5-a]benzimidazol-1-one derivatives with preferential cytotoxicity against carcinoma cell lines / $c J Styskala, L Styskalova, J Slouka, M Hajduch
- 314 __
- $a Department of Organic Chemistry, Faculty of Science, Palacky University, Tr. Svobody 8, 771 46 Olomouc, Czech Republic.
- 520 9_
- $a In this paper we describe the preparation of some derivatives of 1,2,4-triazino[4,5-a]benzimidazol-1-ones (5 and 6), containing additional benzimidazole ring. These compounds were prepared using coupling reactions of diazonium salts with 1,1-bis(1-ethoxycarbonyl-benzimidazol-2-yl)methane (2) to obtain unstable hydrazones 4, which readily undergo cyclization. Interestingly, the selected compounds demonstrated preferential cytotoxic activities against human carcinoma and glioma cell lines compared with leukemic cells. They showed significant activity against multidrug-resistant P-glycoprotein expressing cell lines but had less effect on multidrug-resistance protein 1 positive and topoisomerase IIalpha negative leukemias.
- 650 _2
- $a protinádorové látky $x farmakologie $x chemická syntéza $x chemie $x toxicita $7 D000970
- 650 _2
- $a benzimidazoly $x farmakologie $x chemická syntéza $x chemie $x toxicita $7 D001562
- 650 _2
- $a nádorové buněčné linie $7 D045744
- 650 _2
- $a proliferace buněk $x účinky léků $7 D049109
- 650 _2
- $a racionální návrh léčiv $7 D015195
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a senzitivita a specificita $7 D012680
- 650 _2
- $a financování organizované $7 D005381
- 700 1_
- $a Stýskalová, Libuše $7 xx0143798
- 700 1_
- $a Slouka, Jan, $d 1935- $7 jn20000402233
- 700 1_
- $a Hajdúch, Marián, $d 1969- $7 xx0050218
- 773 0_
- $t European Journal of Medicinal Chemistry $w MED00001628 $g Roč. 43, č. 3 (2008), s. 449-455 $x 0223-5234
- 910 __
- $a ABA008 $b x $y 1
- 990 __
- $a 20110413113630 $b ABA008
- 991 __
- $a 20121203121141 $b ABA008
- 999 __
- $a ok $b bmc $g 830394 $s 694980
- BAS __
- $a 3
- BMC __
- $a 2008 $b 43 $c 3 $d 449-455 $i 0223-5234 $m European journal of medicinal chemistry $n Eur J Med Chem $x MED00001628
- LZP __
- $a 2011-2B/dkme